summit trial tirzepatide JACC Lilly's Tirzepatide Reduced Heart Failure

Smaller volume can ease device constraints and potentially improve comfort, but its also a signal that the company expects high-dose delivery without large depot volumes

That question eventually led to X39

37% of amycretin participants discontinued, though most discontinuations were for non-safety reasons (withdrawal of consent, protocol violations)

135 In humans, AMPK activation from training in a glycogen-depleted state was not influenced by protein intake

Kay is always making sure all of my questions are answered

If you want to see what actually worked for people before deciding anything, the full discussion with real experiences is here